Trials / Terminated
TerminatedNCT00641784
Tocolytics Trial: Intravenous (IV) Magnesium Versus Oral Nifedpine in Fetal Fibronectin (FFN) Postive Population
A Randomized Trial of Oral Nifedipine Versus Intravenous Magnesium Sulfate in the Acute Management of Preterm Labor in Women With Singleton Gestations, Intact Fetal Membranes, and Positive Vaginal Fetal Fibronectin
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- MemorialCare · Academic / Other
- Sex
- Female
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
In women with singleton gestations, to contemporarily assess the efficacy of oral nifedipine versus intravenous magnesium sulfate in the acute management of preterm labor in terms of defined early and late neonatal measures
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Magnesium | Intravenous Magnesium 6 gram load, 3 grams/hr |
| DRUG | Nifedlipine | Oral Nifedpine 10 mgs q 20 min to effect (max 40mgs)...then 20 mgs q 4hrs |
Timeline
- Start date
- 2008-03-01
- Primary completion
- 2012-03-01
- Completion
- 2012-03-01
- First posted
- 2008-03-24
- Last updated
- 2009-09-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00641784. Inclusion in this directory is not an endorsement.